| Pharmaceutical active ingredients: |
| Chlorpheniramine PolistirexCodeine Polistirex |
| Available forms, composition and doses of Codeprex: |
| Suspension, Extended Release; Oral; 4 mg maleate; 20 mg / 5 ml |
| Codeprex medical category: |
| Human:Antitussives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R05DA20 - Opium alkaloids and derivatives, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| UCB Pharma |
| Related documents and information about Codeprex: |
| Codeprex prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Telbon | Chlorpheniramine Maleate; Sulfogaiacol | Novartis |
| Ischemol A | Chlorpheniramine Maleate; Tetrahydrozoline Hydrochloride | Farmila-Thea Farmaceutici |
| Rhinospray Antialergico | Chlorpheniramine Maleate; Tramazoline Hydrochloride | Boehringer Ingelheim |
| Rinogutt Antiallergico Spray | Chlorpheniramine Maleate; Tramazoline Hydrochloride | Boehringer Ingelheim |
| Dirahist | Chlorpheniramine Maleate; Triamcinolone | Teofarma |
| Penntuss | Chlorpheniramine Polistirex; Codeine Polistirex | Fisons; Celltech |
| Atuss-12 DM | Chlorpheniramine Polistirex; Dextromethorphan Polistirex; Pseudoephedrine Polistirex | Atley Pharmaceuticals |
| Hydrocodone; Chlorpheniramine | Chlorpheniramine Polistirex; Hydrocodone Polistirex | Tris Pharma |
| Tussicaps | Chlorpheniramine Polistirex; Hydrocodone Polistirex | Tyco Healthcare |
| Tussionex | Chlorpheniramine Polistirex; Hydrocodone Polistirex | Sanofi-Aventis; UCB Pharma |